ICD-10 Coding for Cancer of Larynx(C10.0, C10.0U, C10.1)
Comprehensive guide to ICD-10 coding for cancer of the larynx, including site-specific codes, documentation requirements, and common pitfalls.
Complete code families applicable to Cancer of Larynx
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C32.0 | Malignant neoplasm of glottis | Use when the tumor is confirmed to be in the glottis with specific documentation. |
|
| C32.1 | Malignant neoplasm of supraglottis | Use when the tumor is confirmed to be in the supraglottis with specific documentation. |
|
| C32.9 | Malignant neoplasm of larynx, unspecified | Use only when the specific subsite of the larynx cannot be determined. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCancer of Larynx
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Cancer of Larynx.
Omitting laterality in documentation
Impact
Clinical: May affect treatment planning and outcomes., Regulatory: Increases risk of audit and compliance issues., Financial: Potential for claim denials or reduced reimbursement.
Mitigation
Always document laterality when known, Use templates that prompt for laterality
Using C32.9 when specific site is documented
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Increases risk of audit due to improper coding., Data Quality: Decreases accuracy of clinical data.
Mitigation
Use the specific site code (e.g., C32.0 for glottis) when documentation supports it.
Use of unspecified codes
Impact
Frequent use of C32.9 without documentation of exhaustive workup.
Mitigation
Ensure documentation supports the use of unspecified codes only when necessary.